Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DNAH9 DNAH17 DNAH11	4.17e-05	18	224	4	GO:0008569
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO7A MYO9B MYO3B DNAH5 DNAH9 MYO1H DNAH17 DNAH11	5.62e-05	118	224	8	GO:0003774
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-kinase activity	PIK3CD PIK3R3 ATM	2.15e-04	11	224	3	GO:0016303
GeneOntologyMolecularFunction	protein serine kinase activity	CDK8 RIPK1 SRPK1 SRPK2 MYO3B RAF1 MTOR CSNK2A2 HASPIN TNK2 ATM PRKG2 PINK1	2.46e-04	363	224	13	GO:0106310
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH5 DNAH9 DNAH17 DNAH11	2.55e-04	28	224	4	GO:0051959
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK8 RIPK1 PAPOLB SRPK1 SRPK2 PIGG NRP1 BMX PIK3CD MYO3B FGFR2 RAF1 PIK3R3 PARP14 TRNT1 MTOR CSNK2A2 HASPIN TNK2 ROS1 ATM PRKG2 PINK1	3.75e-04	938	224	23	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDK8 RIPK1 SRPK1 SRPK2 NRP1 BMX PIK3CD MYO3B FGFR2 RAF1 PIK3R3 MTOR CSNK2A2 HASPIN TNK2 ROS1 ATM PRKG2 PINK1	4.23e-04	709	224	19	GO:0016773
GeneOntologyMolecularFunction	protein kinase activity	CDK8 RIPK1 SRPK1 SRPK2 NRP1 BMX MYO3B FGFR2 RAF1 MTOR CSNK2A2 HASPIN TNK2 ROS1 ATM PRKG2 PINK1	4.57e-04	600	224	17	GO:0004672
GeneOntologyBiologicalProcess	peptidyl-amino acid modification	IFNK ERCC6 RIPK1 SRPK1 SRPK2 NRP1 MYO3B FGFR2 PLCG2 RAB3B SENP5 TRAF7 RAF1 RANBP2 RAB3D PARP14 AGBL3 PRMT6 SLF2 MTOR CFAP20 CSNK2A2 LRP4 TNK2 ROS1 ATM IL3 PINK1	1.91e-06	976	220	28	GO:0018193
GeneOntologyCellularComponent	9+0 motile cilium	ENKUR DNAH5 DNAH11	2.40e-05	6	225	3	GO:0097728
GeneOntologyCellularComponent	outer dynein arm	DNAH5 DNAH9 DNAH17	2.52e-04	12	225	3	GO:0036157
GeneOntologyCellularComponent	activating signal cointegrator 1 complex	TRIP4 ASCC3	3.44e-04	3	225	2	GO:0099053
GeneOntologyCellularComponent	axoneme	ENKUR DNAH5 DNAH9 SPEF1 CFAP20 DNAH17 RP1 CFAP46 DNAH11	4.23e-04	207	225	9	GO:0005930
GeneOntologyCellularComponent	myosin complex	MYO7A MYO9B MYO3B MYO1H CGNL1	4.31e-04	59	225	5	GO:0016459
GeneOntologyCellularComponent	ciliary plasm	ENKUR DNAH5 DNAH9 SPEF1 CFAP20 DNAH17 RP1 CFAP46 DNAH11	4.38e-04	208	225	9	GO:0097014
GeneOntologyCellularComponent	KICSTOR complex	KICS2 SZT2	6.82e-04	4	225	2	GO:0140007
Domain	DHC_N1	DNAH5 DNAH9 DNAH11	8.64e-05	8	220	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DNAH9 DNAH11	8.64e-05	8	220	3	IPR013594
Domain	WD40_repeat_dom	WSB2 WDR53 WDR3 IFT80 WDR1 WDR49 RIC1 TRAF7 UBR4 ARHGEF10 WDR87 HPS5	2.20e-04	297	220	12	IPR017986
Domain	Kinase-like_dom	CDK8 RIPK1 SRPK1 SRPK2 BMX PIK3CD MYO3B FGFR2 RAF1 MTOR CSNK2A2 HASPIN TNK2 ROS1 ATM PRKG2 PINK1	2.47e-04	542	220	17	IPR011009
Domain	Spectrin_repeat	SPTBN1 PLEC DRP2 SYNE1	3.53e-04	29	220	4	IPR002017
Domain	SPEC	SPTBN1 PLEC DRP2 SYNE1	5.20e-04	32	220	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN1 PLEC DRP2 SYNE1	5.20e-04	32	220	4	IPR018159
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	IPR013602
Domain	DHC_N2	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	IPR011704
Domain	MT	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	PF12777
Domain	AAA_8	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	PF12780
Domain	AAA_5	DNAH5 DNAH9 DNAH11	5.33e-04	14	220	3	PF07728
Domain	DHC_fam	DNAH5 DNAH9 DNAH11	6.61e-04	15	220	3	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH9 DNAH11	6.61e-04	15	220	3	PF03028
Domain	PI3/4_kinase_CS	PIK3CD MTOR ATM	6.61e-04	15	220	3	IPR018936
Domain	LY	LRP4 LRP6 ROS1	6.61e-04	15	220	3	SM00135
Domain	Dynein_heavy_dom	DNAH5 DNAH9 DNAH11	6.61e-04	15	220	3	IPR004273
Domain	LDLR_classB_rpt	LRP4 LRP6 ROS1	6.61e-04	15	220	3	IPR000033
Domain	-	PIK3CD MTOR ATM	8.06e-04	16	220	3	1.10.1070.11
Domain	PI3Kc	PIK3CD MTOR ATM	8.06e-04	16	220	3	SM00146
Domain	Alk_phosphatase	ALPI ALPG	8.16e-04	4	220	2	PF00245
Domain	Alkaline_phosphatase_AS	ALPI ALPG	8.16e-04	4	220	2	IPR018299
Domain	Alkaline_phosphatase	ALPI ALPG	8.16e-04	4	220	2	IPR001952
Domain	alkPPc	ALPI ALPG	8.16e-04	4	220	2	SM00098
Domain	ALKALINE_PHOSPHATASE	ALPI ALPG	8.16e-04	4	220	2	PS00123
Domain	Pkinase_Tyr	RIPK1 BMX FGFR2 RAF1 HASPIN TNK2 ROS1	8.49e-04	129	220	7	PF07714
Domain	-	NHLRC2 LRP4 LRP6 ROS1	1.12e-03	39	220	4	2.120.10.30
Domain	PI3_PI4_kinase	PIK3CD MTOR ATM	1.15e-03	18	220	3	PF00454
Domain	PI3_4_KINASE_1	PIK3CD MTOR ATM	1.15e-03	18	220	3	PS00915
Domain	PI3_4_KINASE_2	PIK3CD MTOR ATM	1.15e-03	18	220	3	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3CD MTOR ATM	1.15e-03	18	220	3	IPR000403
Domain	PI3_4_KINASE_3	PIK3CD MTOR ATM	1.15e-03	18	220	3	PS50290
Domain	Ser-Thr/Tyr_kinase_cat_dom	RIPK1 BMX FGFR2 RAF1 HASPIN TNK2 ROS1	1.26e-03	138	220	7	IPR001245
Domain	LRRC8_Pannexin-like	LRRC8E LRRC8D	1.35e-03	5	220	2	IPR021040
Domain	Pannexin_like	LRRC8E LRRC8D	1.35e-03	5	220	2	PF12534
Domain	FATC	MTOR ATM	1.35e-03	5	220	2	PF02260
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CDK8 ERCC6 DCDC1 ATAD5 SRPK2 CLSTN2 TRIP4 ISY1 ZNF512B CACTIN PTPN14 ANAPC1 ASCC3 TRAF7 RAF1 HECTD3 NSD2 PIK3R3 VPS50 ZC3H18 TRMT2A CCNB3 CSNK2A2 LRP4 ZFHX3 KAT14 TCF7L1	6.87e-09	1116	229	27	31753913
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH5 DNAH9 DNAH17 DNAH11	6.31e-08	7	229	4	31178125
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 ATAD5 SPTBN1 SRPK1 SRPK2 TIMMDC1 TRIP4 ZNF512B WDR3 CACTIN PTPN14 ERAP2 IFT80 ASCC3 DNAJB5 TBC1D15 HECTD3 SYNE1 PIK3R3 UBR4 POR E2F6 PREPL ARL2 ARHGEF10 ATM NBR1 EXOC4 TPI1	1.92e-07	1487	229	29	33957083
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SDSL MYO7A MYO9B IPP PIGG ITGB5 PIK3CD FGFR2 PLEC RIC1 LRRC8E TRAF7 SZT2 NSD2 UBR4 RTTN SBNO2 CELSR1 MTOR USP40 LRP4 TNK2 SNAPC4 MYBL2	3.58e-07	1105	229	24	35748872
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ANAPC1 PLEC ASCC3 SFMBT1 RAF1 RANBP2 TBC1D15 UBR4 E2F6 RUFY1 ZFHX3 KAT14 EXOC4 MYBL2	8.50e-07	418	229	14	34709266
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SOX9 ATP6V1A ATAD5 GPATCH8 ISY1 CDC45 WDR3 CACTIN ANAPC1 PLEC ARIH1 WDR1 MED17 RANBP2 NSD2 UBR4 ZC3H18 PRMT6 TRNT1 CSNK2A2 ATM TPI1	1.15e-06	1014	229	22	32416067
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDK8 RALGAPA1 ATP6V1A SRPK2 SESN1 ITGB5 ITFG1 NRP1 TBC1D14 ARIH1 RIC1 STEAP1 NSD2 PIK3R3 SELENON LRRC8D INTS8 SBNO2 TRNT1 TJP1 USP40 TTC21B TNK2 ZFHX3 HPS5 NBR1 EXOC4	2.09e-06	1489	229	27	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 GMEB2 ZNF512B TRANK1 IFT80 SYT13 SDK2 SZT2 NSD2 VPS50 CACHD1 PREPL LRP4 HPS5 NBR1	2.70e-06	529	229	15	14621295
Pubmed	DNAH11 Localization in the Proximal Region of Respiratory Cilia Defines Distinct Outer Dynein Arm Complexes.	DNAH5 DNAH9 DNAH11	2.79e-06	5	229	3	26909801
Pubmed	CFAP53 regulates mammalian cilia-type motility patterns through differential localization and recruitment of axonemal dynein components.	DNAH5 DNAH9 DNAH11	5.55e-06	6	229	3	33347437
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CDK8 GJD2 WSB2 NHLRC2 GPATCH8 TIMMDC1 FAM186B ITGB5 CDC45 ANAPC1 KICS2 ATP13A3 RBM18 OR2F2 SZT2 UBR4 ZC3H18 RUFY1 PREPL TRMT2A CFAP20 CENPI KAT14 CAPN15	8.38e-06	1327	229	24	32694731
Pubmed	Wnt ligand/Frizzled 2 receptor signaling regulates tube shape and branch-point formation in the lung through control of epithelial cell shape.	SOX9 FGFR2 CELSR1 TCF7L1	1.00e-05	21	229	4	25114215
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	MYO9B SPTBN1 PTPN14 PLEC WDR1 DNAH5 NSD2 PARP14 CDCP1 ARHGEF10 SEC14L5	1.43e-05	332	229	11	37433992
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SOX9 EPRS1 SPTBN1 SRPK2 USP9Y ZNF512B WDR3 TPP1 PLEC VARS1 DSCAM SYNE1 UBR4 CACHD1 INTS8 PREPL ARHGEF10 SLF2 TJP1 LRP4 ATM PINK1 EXOC4	1.54e-05	1285	229	23	35914814
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	EPRS1 SAMD9 SRPK1 SRPK2 NRP1 CDC45 TPP1 RIC1 RAF1 HECTD3 SBNO2 KLHL11 TRMT2A HPS5 EXOC4	3.06e-05	650	229	15	38777146
Pubmed	An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma.	PIK3CD NLRP3 IL1R1	3.27e-05	10	229	3	21474346
Pubmed	USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells.	SPTBN1 NRP1 CPS1	3.27e-05	10	229	3	36653359
Pubmed	Generation and analysis of 280,000 human expressed sequence tags.	EPRS1 ADARB2 ABCA9 PIK3CD SYT13 HECTD3 CPS1 INTS8 CROT TJP1 LRP6	3.68e-05	368	229	11	8889549
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	RIPK1 SRPK1 WSB2 BMX MYO3B RAF1 HECTD3 HASPIN TNK2 PRKG2 PINK1	4.05e-05	372	229	11	22939624
Pubmed	CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.	RAF1 PRMT6	4.32e-05	2	229	2	31469916
Pubmed	The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro.	SRPK1 SRPK2	4.32e-05	2	229	2	32817937
Pubmed	SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.	SOX9 MTOR	4.32e-05	2	229	2	29550418
Pubmed	Inflammasome-independent NLRP3 function enforces ATM activity in response to genotoxic stress.	NLRP3 ATM	4.32e-05	2	229	2	36746533
Pubmed	Putative homeodomain transcription factor 1 interacts with the feminization factor homolog fem1b in male germ cells.	FEM1B PHTF1	4.32e-05	2	229	2	15601915
Pubmed	The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.	CYP4Z1 CYP4Z2P	4.32e-05	2	229	2	28236635
Pubmed	Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.	SRPK1 SRPK2	4.32e-05	2	229	2	12134018
Pubmed	PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway.	PIK3CD NLRP3	4.32e-05	2	229	2	34162771
Pubmed	Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.	CYP4Z1 CYP4Z2P	4.32e-05	2	229	2	15059886
Pubmed	The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm.	NLRP3 IL1R1	4.32e-05	2	229	2	24988285
Pubmed	A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses.	NLRP3 IL1R1	4.32e-05	2	229	2	19501001
Pubmed	Cytochrome P450 Oxidoreductase Deficiency	FGFR2 POR	4.32e-05	2	229	2	20301592
Pubmed	Rare variants in dynein heavy chain genes in two individuals with situs inversus and developmental dyslexia: a case report.	DNAH5 DNAH11	4.32e-05	2	229	2	32357925
Pubmed	Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).	SRPK1 SRPK2	4.32e-05	2	229	2	26244849
Pubmed	IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils.	CD86 IL3	4.32e-05	2	229	2	11714768
Pubmed	Muscle regulates mTOR dependent axonal local translation in motor neurons via CTRP3 secretion: implications for a neuromuscular disorder, spinal muscular atrophy.	C1QTNF3 MTOR	4.32e-05	2	229	2	31615574
Pubmed	The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene.	POR KAT14	4.32e-05	2	229	2	20808945
Pubmed	Neuronal connexin36 association with zonula occludens-1 protein (ZO-1) in mouse brain and interaction with the first PDZ domain of ZO-1.	GJD2 TJP1	4.32e-05	2	229	2	15090040
Pubmed	Serine-arginine protein kinases: a small protein kinase family with a large cellular presence.	SRPK1 SRPK2	4.32e-05	2	229	2	21205200
Pubmed	FERM domain-containing unconventional myosin VIIA interacts with integrin β5 subunit and regulates αvβ5-mediated cell adhesion and migration.	MYO7A ITGB5	4.32e-05	2	229	2	24997346
Pubmed	The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.	CYP4Z1 CYP4Z2P	4.32e-05	2	229	2	25701119
Pubmed	Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles.	SRPK1 SRPK2	4.32e-05	2	229	2	9446799
Pubmed	The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.	NLRP3 IL1R1	4.32e-05	2	229	2	30858427
Pubmed	Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery.	IL1R1 IL3	4.32e-05	2	229	2	22515947
Pubmed	A Single Mechanism of Biogenesis, Initiated and Directed by PIWI Proteins, Explains piRNA Production in Most Animals.	PNLDC1 PIWIL2	4.32e-05	2	229	2	30193099
Pubmed	PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation.	NLRP3 PINK1	4.32e-05	2	229	2	32947010
Pubmed	Inhibition of mammalian target of rapamycin signaling pathway decreases retinoic acid stimulated gene 8 expression in adult mouse testis.	STRA8 MTOR	4.32e-05	2	229	2	25241363
Pubmed	Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.	NLRP3 IL1R1	4.32e-05	2	229	2	29886157
Pubmed	Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.	MTOR ROS1	4.32e-05	2	229	2	31053160
Pubmed	Cockayne Syndrome group B protein stimulates NEIL2 DNA glycosylase activity.	ERCC6 NEIL2	4.32e-05	2	229	2	24406253
Pubmed	Rapamycin attenuates endothelial apoptosis induced by low shear stress via mTOR and sestrin1 related redox regulation.	SESN1 MTOR	4.32e-05	2	229	2	24587596
Pubmed	ADAR3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice.	ADARB2 NLRP3	4.32e-05	2	229	2	34419568
Pubmed	Therapeutic Potential for FGFR Inhibitors in SOX9-FGFR2 Coexpressing Pancreatic Cancer.	SOX9 FGFR2	4.32e-05	2	229	2	28796141
Pubmed	Stem Cell Factor SOX9 Interacts with a Cell Death Regulator RIPK1 and Results in Escape of Cancer Stem Cell Death.	SOX9 RIPK1	4.32e-05	2	229	2	35159173
Pubmed	Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury.	NLRP3 PINK1	4.32e-05	2	229	2	24778451
Pubmed	Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.	SRPK1 SRPK2	4.32e-05	2	229	2	20498328
Pubmed	Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex.	PIK3CD PLCG2	4.32e-05	2	229	2	12446777
Pubmed	Ciliary defects and genetics of primary ciliary dyskinesia.	DNAH5 DNAH11	4.32e-05	2	229	2	19410201
Pubmed	mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus.	NLRP3 MTOR	4.32e-05	2	229	2	30060081
Pubmed	Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation.	NLRP3 IL1R1	4.32e-05	2	229	2	28747793
Pubmed	Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.	SRPK1 SRPK2	4.32e-05	2	229	2	16122776
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	RALGAPA1 ATP6V1A RIPK1 PIGG TRIP4 ATP13A3 ASCC3 TRAF7 TBC1D15 NSD2 POR ZC3H18 TRMT2A MTOR CSNK2A2 JRK	4.54e-05	754	229	16	33060197
Pubmed	Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling.	SOX9 FGFR2 MTOR LRP6	5.70e-05	32	229	4	34193412
Pubmed	A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.	SRPK2 CLSTN2 CNTN5 DNAH9	5.70e-05	32	229	4	23049088
Pubmed	A novel mouse Fgfr2 mutant, hobbyhorse (hob), exhibits complete XY gonadal sex reversal.	SOX9 STRA8 FGFR2	5.93e-05	12	229	3	24956260
Pubmed	Rheb binds and regulates the mTOR kinase.	RAF1 MTOR ATM	5.93e-05	12	229	3	15854902
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EPRS1 SPTBN1 GPATCH8 CACTIN ANAPC1 PLEC ALPI RANBP2 ZC3H18 NSUN5 CSNK2A2 ELF1 ATM SNAPC4 ZHX1 MYBL2	6.17e-05	774	229	16	15302935
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	EPRS1 MYO9B SRPK1 ANAPC1 PLEC ASCC3 PARP14 MTOR	6.25e-05	202	229	8	33005030
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	TBC1D14 TXNDC16 IFT80 CCDC191 SYT13 RIC1 UBR4	7.35e-05	153	229	7	10718198
Pubmed	Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β.	WDR1 NLRP3 IL1R1	7.67e-05	13	229	3	26008898
Pubmed	Testis development requires the repression of Wnt4 by Fgf signaling.	SOX9 NRP1 FGFR2	7.67e-05	13	229	3	22705479
Pubmed	Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.	PLEC CPS1 NLRP3 IL1R1	8.17e-05	35	229	4	23969696
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	ERCC6 GPATCH8 WDR3 ANAPC1 PLEC RANBP2 CENPI HASPIN	8.20e-05	210	229	8	16565220
Pubmed	Phospho-tyrosine dependent protein-protein interaction network.	NHLRC2 BMX C1QTNF3 PLCG2 MNDA SFMBT1 PIK3R3 AKNAD1 E2F6 TNK2 PINK1	9.64e-05	410	229	11	25814554
Pubmed	Loss of Fgfr2 leads to partial XY sex reversal.	SOX9 STRA8 FGFR2	9.72e-05	14	229	3	18155190
Pubmed	PAX6 regulates melanogenesis in the retinal pigmented epithelium through feed-forward regulatory interactions with MITF.	SOX9 MYO7A TJP1	9.72e-05	14	229	3	24875170
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH5 DNAH17 DNAH11	9.72e-05	14	229	3	9373155
Pubmed	General transcription factor TAF4 antagonizes epigenetic silencing by Polycomb to maintain intestine stem cell functions.	SOX9 ALPI ALPG	9.72e-05	14	229	3	36639541
Pubmed	Defining the membrane proteome of NK cells.	EPRS1 MYO9B PIGG C1QTNF3 ATP13A3 ASCC3 MED17 RUSF1 STEAP1 RANBP2 UBR4 VPS50 POR PARP14 LRRC8D MTOR TNK2 NBR1 ACSL5 EXOC4	1.03e-04	1168	229	20	19946888
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	SOX9 MYO7A TPP1 CELSR1 LRP4	1.16e-04	72	229	5	25917818
Pubmed	Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo.	ITGB5 NLRP3 IL1R1	1.21e-04	15	229	3	19576795
Pubmed	CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability.	MTOR CSNK2A2 ATM	1.21e-04	15	229	3	20864032
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SPTBN1 SRPK1 WDR3 ANAPC1 PLEC ASCC3 RANBP2 NSD2 UBR4 ZC3H18 TJP1 MTOR CSNK2A2 ATM	1.22e-04	653	229	14	22586326
Pubmed	Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes.	PIK3CD MTOR	1.29e-04	3	229	2	19013287
Pubmed	SOX9 promotes nasopharyngeal carcinoma cell proliferation, migration and invasion through BMP2 and mTOR signaling.	SOX9 MTOR	1.29e-04	3	229	2	31357026
Pubmed	Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.	MTOR TNK2	1.29e-04	3	229	2	32162707
Pubmed	Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells.	NLRP3 IL1R1	1.29e-04	3	229	2	31935195
Pubmed	Characterisation and use of a functional Gadd45g bacterial artificial chromosome.	SOX9 STRA8	1.29e-04	3	229	2	30470800
Pubmed	Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.	RIPK1 NLRP3	1.29e-04	3	229	2	32321638
Pubmed	Discovery of a Role for Rab3b in Habituation and Cocaine Induced Locomotor Activation in Mice Using Heterogeneous Functional Genomic Analysis.	RAB3B RAB3D	1.29e-04	3	229	2	32742255
Pubmed	SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.	SRPK1 SRPK2	1.29e-04	3	229	2	23197718
Pubmed	IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.	NLRP3 IL1R1	1.29e-04	3	229	2	36758176
Pubmed	PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L.	SAMD9 PARP14	1.29e-04	3	229	2	37612499
Pubmed	Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.	NLRP3 IL1R1	1.29e-04	3	229	2	21048113
Pubmed	Transient expression of SOX9 protein during follicular development in the adult mouse ovary.	SOX9 POR	1.29e-04	3	229	2	16488195
Pubmed	Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop.	NLRP3 PINK1	1.29e-04	3	229	2	29665074
Pubmed	Cardiac arrhythmias after renal I/R depend on IL-1β.	NLRP3 IL1R1	1.29e-04	3	229	2	31029578
Pubmed	Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.	SOX9 MTOR	1.29e-04	3	229	2	27991928
Pubmed	Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases.	ALPI ALPG	1.29e-04	3	229	2	3443302
Pubmed	Rhox8 Ablation in the Sertoli Cells Using a Tissue-Specific RNAi Approach Results in Impaired Male Fertility in Mice.	SOX9 STRA8	1.29e-04	3	229	2	25972016
Pubmed	Requirement for PLCγ2 in IL-3 and GM-CSF-stimulated MEK/ERK phosphorylation in murine and human hematopoietic stem/progenitor cells.	PLCG2 IL3	1.29e-04	3	229	2	21506110
Cytoband	1p13.3	NBPF4 NBPF5P AKNAD1 NBPF6 PRMT6	2.56e-05	69	229	5	1p13.3
GeneFamily	Dyneins, axonemal	DNAH5 DNAH9 DNAH17 DNAH11	1.05e-05	17	152	4	536
GeneFamily	Alkaline phosphatases	ALPI ALPG	4.17e-04	4	152	2	1072
GeneFamily	Volume regulated anion channel subunits	LRRC8E LRRC8D	6.91e-04	5	152	2	1158
GeneFamily	Neuroblastoma breakpoint family	NBPF4 NBPF5P NBPF6	9.12e-04	23	152	3	662
GeneFamily	WD repeat domain containing	WSB2 WDR53 WDR3 IFT80 WDR1 WDR49 TRAF7 WDR87	1.70e-03	262	152	8	362
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	ABCA9 NRP1 PTPN14 ERAP2 MYO3B TPRG1 PARP14 CDCP1 SLFN12L RSAD2 CENPI CGNL1 SLC14A2 LRRC36	7.65e-06	384	228	14	M798
Coexpression	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	EPSTI1 PARP14 TDRD7 RSAD2 SLF2 CD86 HASPIN ELF1 CCDC171 EXOC4	1.08e-05	200	228	10	M8559
Coexpression	GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	SPTBN1 SRPK1 WDR3 KICS2 NT5DC3 TDRD7 CD86 RP1 ATM DNAH11	1.08e-05	200	228	10	M5068
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	ERCC6 STRA8 IPP PNLDC1 GPATCH8 CDC45 TRANK1 PLCG2 CCDC191 SFMBT1 ASZ1 PIK3R3 VPS50 PIWIL2 CINP TDRD7 MTOR CENPI HASPIN USP40 PDE5A ATM CCDC171 PHTF1 MYBL2	1.89e-06	820	223	25	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	4.57e-09	190	229	11	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	4.57e-09	190	229	11	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	5.99e-09	195	229	11	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.32e-09	196	229	11	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.66e-09	197	229	11	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 CLSTN2 VWA3B DNAH5 CCDC191 DNAH9 WDR49 SYNE1 RP1 CFAP46 DNAH11	6.66e-09	197	229	11	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.66e-09	197	229	11	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.66e-09	197	229	11	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ENKUR DCDC1 DNAH5 CCDC191 DNAH9 WDR49 SPEF1 SYNE1 RP1 CFAP46 DNAH11	7.80e-09	200	229	11	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENKUR MYO7A DNAH9 SPEF1 SYTL3 PDE5A SNAPC4 SLC14A2 LRRC36 DNAH11	2.93e-08	177	229	10	e8bb4f8ecd5e283efec966b9fc2040a6152d5551
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP24A1 CES2 VWA3B DNAH5 RAB3B DNAH9 WDR49 RP1 CFAP46 DNAH11	3.44e-08	180	229	10	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	4.45e-08	185	229	10	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC1 CYP24A1 ADARB2 NRP1 PTPN14 SYNE1 SYTL3 RP1 TCF7L1 DNAH11	4.69e-08	186	229	10	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	4.69e-08	186	229	10	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	CYP24A1 ADARB2 PTPN14 FGFR2 DNAH5 CACHD1 CELSR1 CROT LRP4 TCF7L1	4.93e-08	187	229	10	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.45e-08	189	229	10	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.45e-08	189	229	10	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	Ciliated\|World / shred by cell class for parenchyma	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.45e-08	189	229	10	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	(12)_SLC16A7+\|World / shred by cell type by condition	DCDC1 ABCA9 MYO3B DNAH5 DNAH9 SPEF1 RSAD2 RP1 CFAP46 DNAH11	6.02e-08	191	229	10	e427eeddd2e87c14376a37db0b43f120c90436bc
ToppCell	LAM-Epithelial-AirwayEpi\|LAM / Condition, Lineage and Cell class	SOX9 ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.32e-08	192	229	10	7404fc65be3b7bd09447725b43fa31819004dfee
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.32e-08	192	229	10	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 VWA3B DNAH5 DNAH9 WDR49 CACHD1 CELSR1 RP1 CFAP46 DNAH11	6.64e-08	193	229	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 SYNE1 RP1 CFAP46 DNAH11	6.64e-08	193	229	10	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 CCDC191 DNAH9 SYNE1 RP1 CFAP46 DNAH11	6.97e-08	194	229	10	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.97e-08	194	229	10	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 PLCG2 DNAH5 CCDC191 DNAH9 WDR49 SYNE1 RP1 CFAP46 DNAH11	6.97e-08	194	229	10	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 CCDC191 DNAH9 SYNE1 RP1 CFAP46 DNAH11	6.97e-08	194	229	10	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DCDC1 SPTBN1 VWA3B DNAH5 DNAH9 SYNE1 CYP4Z2P RP1 CFAP46 DNAH11	7.31e-08	195	229	10	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DCDC1 SPTBN1 VWA3B DNAH5 DNAH9 SYNE1 CYP4Z2P RP1 CFAP46 DNAH11	7.31e-08	195	229	10	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.31e-08	195	229	10	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	69f5081e06d84ec1d9695762df801a9d0df1984b
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.67e-08	196	229	10	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SYNE1 RP1 CFAP46 DNAH11	8.43e-08	198	229	10	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	9.26e-08	200	229	10	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	9.26e-08	200	229	10	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	9.26e-08	200	229	10	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Ciliated\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	9.26e-08	200	229	10	d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	9.26e-08	200	229	10	cf59110547cc66b5f4a2999735336b0309ba9b0d
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C2orf69 CENPA SESN1 ABCA9 DNAJB5 SFMBT1 RTTN TLR5 MYBL2	2.94e-07	173	229	9	12c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	3.74e-07	178	229	9	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	4.31e-07	181	229	9	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ENKUR CLSTN2 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	4.51e-07	182	229	9	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	Ciliated_cells-B-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	ENKUR DCDC1 CNTN5 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46	4.51e-07	182	229	9	e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	4.73e-07	183	229	9	cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	4.73e-07	183	229	9	b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.18e-07	185	229	9	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	5.18e-07	185	229	9	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B RAB3B DNAH9 WDR49 SPEF1 CFAP46 DNAH11	5.42e-07	186	229	9	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ENKUR DCDC1 CNTN5 VWA3B DNAH9 SPEF1 RP1 CFAP46 DNAH11	5.42e-07	186	229	9	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DCDC1 VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.67e-07	187	229	9	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	5.92e-07	188	229	9	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.92e-07	188	229	9	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	5.92e-07	188	229	9	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	5.92e-07	188	229	9	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.19e-07	189	229	9	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.19e-07	189	229	9	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.19e-07	189	229	9	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.47e-07	190	229	9	169e600e95878000acf5d11f813f9028c7249646
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.47e-07	190	229	9	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.47e-07	190	229	9	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.47e-07	190	229	9	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)\|356C / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	e314dd8f1a841cab847ae3703bedfe1bc623ac61
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ENKUR DCDC1 DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	8a5a2188b13ef4bbfd626a42565566708a751c1b
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR DCDC1 VWA3B DNAH5 DNAH9 WDR49 RP1 CFAP46 DNAH11	6.76e-07	191	229	9	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|normal_Lung / Location, Cell class and cell subclass	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	7.07e-07	192	229	9	097a13121820ab4e5cd2365600efccf5ea4ce8c3
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	7.07e-07	192	229	9	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	7.07e-07	192	229	9	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DCDC1 VWA3B DNAH5 DNAH9 SPEF1 CYP4Z2P RP1 CFAP46 DNAH11	7.07e-07	192	229	9	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	Bronchial_Brush\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	7.38e-07	193	229	9	3e693ac4c92576e3f2c9efdd3f1d96d3d336e260
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DCDC1 VWA3B DNAH5 DNAH9 WDR49 SYNE1 RP1 CFAP46 DNAH11	7.38e-07	193	229	9	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PEBP4 VWA3B DNAH5 SYNE1 ROS1 RP1 LRRC36 CFAP46 DNAH11	7.38e-07	193	229	9	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ENKUR VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	7.70e-07	194	229	9	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	7.70e-07	194	229	9	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	18-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	ENKUR VWA3B DNAH5 DNAH9 WDR49 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	3441381759cd00d125752401dc99b78be1c78f88
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR DCDC1 VWA3B DNAH5 CCDC191 DNAH9 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 EPSTI1 TRANK1 MNDA PARP14 TDRD7 SLFN12L RSAD2 ELF1	8.04e-07	195	229	9	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR DCDC1 VWA3B DNAH5 DNAH9 SPEF1 RP1 CFAP46 DNAH11	8.04e-07	195	229	9	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	PEBP4 FGFR2 DNAH5 SYNE1 CACHD1 CYP4Z2P ROS1 CGNL1 LRRC36	8.04e-07	195	229	9	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	SAMD9 EPSTI1 TRANK1 ERAP2 TBX21 PARP14 SLFN12L RSAD2 ELF1	8.39e-07	196	229	9	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DCDC1 SPTBN1 DNAH5 DNAH9 SYNE1 CYP4Z2P RP1 CFAP46 DNAH11	8.39e-07	196	229	9	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	Mild-CD4+_T_activated\|World / Disease group and Cell class	SAMD9 EPSTI1 TRANK1 ERAP2 PARP14 TDRD7 SLFN12L RSAD2 ELF1	8.39e-07	196	229	9	417b4fc2e4388f34c410576131b02936f93e46b6
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DCDC1 SPTBN1 DNAH5 DNAH9 SYNE1 CYP4Z2P RP1 CFAP46 DNAH11	8.39e-07	196	229	9	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	DCDC1 VWA3B DNAH5 DNAH9 CYP4Z2P CELSR1 RP1 CFAP46 DNAH11	8.39e-07	196	229	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 VWA3B DNAH5 CCDC191 DNAH9 SYNE1 RP1 CFAP46 DNAH11	8.75e-07	197	229	9	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	wk_20-22-Epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ENKUR VWA3B DNAH5 DNAH9 SPEF1 CELSR1 RP1 CFAP46 DNAH11	8.75e-07	197	229	9	468071c1911cdf8e8806a78dbceb95379e28ae91
Drug	Arecoline hydrobromide [300-08-3]; Down 200; 17uM; HL60; HT_HG-U133A	ATP6V1A SRPK2 ATP13A3 WDR1 NSD2 PIK3R3 PREPL FEM1B PHTF1 PINK1 TTC33	4.26e-06	195	226	11	1303_DN
Drug	4-hydroxy-2-nonenal	ATP6V1A EPSTI1 CENPA ATAD5 WSB2 SRPK2 CES2 NRP1 PIK3CD MNDA RAF1 NLRP3 SBNO2 CROT RSAD2 TJP1 MTOR CD86 HASPIN ATM IL3 MYBL2 TPI1	5.06e-06	798	226	23	ctd:C027576
Drug	IC261	MYO7A PLEC DNAH5 DNAH9 RAF1 CSNK2A2 DNAH17 DNAH11	5.21e-06	96	226	8	CID000003674
Drug	vanadyl	MYO7A PIK3CD PLCG2 DNAH5 DNAH9 ALPI RAF1 PIK3R3 DNAH17 LRP6 PDE5A IL3 DNAH11	1.32e-05	307	226	13	CID000061671
Drug	Anthocyanins	POR NLRP3 TJP1 PDE5A ATM	2.35e-05	35	226	5	ctd:D000872
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	RALGAPA1 ZNF862 BAAT PIK3CD CNTN5 DNAJB5 SENP5 NT5DC3 SLC14A2 SEC14L5	2.79e-05	196	226	10	6782_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	RALGAPA1 ZNF862 ZNF512B CACTIN DNAJB5 HECTD3 RAB3D SBNO2 LRP6 TNK2	2.79e-05	196	226	10	3118_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	GJD2 SPTBN1 TRANK1 SZT2 CPS1 NT5DC3 SBNO2 CROT DNAH17 PRKG2	2.91e-05	197	226	10	2328_UP
Drug	Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A	ATAD5 SLC24A3 ATP13A3 MNDA RUSF1 SYNE1 TLR5 LRP6 TNK2 IL1R1	3.04e-05	198	226	10	4947_UP
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	SAMD9 CACTIN PLEC RUSF1 NSD2 IL17RC CINP FEM1B ARL2 CAPN15	3.04e-05	198	226	10	1812_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; PC3; HT_HG-U133A	SPTBN1 SRPK2 CDC45 ZNF512B CACTIN RUSF1 POR CINP FEM1B ELF1	3.04e-05	198	226	10	6290_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A	ZNF862 CES2 PTPN14 TPP1 SZT2 CINP MLYCD ARHGEF10 LRP6 ZFHX3	3.04e-05	198	226	10	4579_DN
Disease	alkaline phosphatase measurement	RALGAPA1 SAMD9 AOC1 NEIL2 STRA8 CYP24A1 SPTBN1 ZNF512B TRANK1 RIC1 TRAF7 CPS1 NLRP3 SBNO2 MLYCD PRMT6 SLF2 FGFBP3 ELF1 RP1 PHTF1 PINK1 PHLPP2	2.26e-06	1015	219	23	EFO_0004533
Disease	blood urea nitrogen measurement	DCDC1 CYP24A1 ASCC3 POR CPS1 SLF2 JRK TTC21B TNK2 HPS5 CCDC171 SLC14A2 TCF7L1 TTC33	8.13e-06	452	219	14	EFO_0004741
Disease	serum metabolite measurement	RALGAPA1 AOC1 RIPK1 ZNF862 CYP24A1 IPP SLC24A3 SRPK2 ERAP2 TXNDC16 PLCG2 WDR1 RIC1 PIK3R3 LINGO2 CPS1 CYP4Z2P DNAH17 ZFHX3 HPS5 PHLPP2	8.56e-06	945	219	21	EFO_0005653
Disease	mean platelet volume	AOC1 MYO9B ATAD5 CYP24A1 SPTBN1 SLC24A3 ZNF512B TRANK1 TBC1D14 ATP13A3 PLCG2 PLEC RAB3B WDR49 RTTN NBPF6 CPS1 LRRC8D CD86 SEC14L5 ACSL5	2.65e-05	1020	219	21	EFO_0004584
Disease	Lambert-Eaton Myasthenic Syndrome	PLEC PREPL	5.48e-05	2	219	2	C0022972
Disease	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	FGFR2 POR	5.48e-05	2	219	2	cv:C2936791
Disease	Antley-Bixler Syndrome with Disordered Steroidogenesis	FGFR2 POR	5.48e-05	2	219	2	C1860042
Disease	Myasthenic Syndrome	PLEC PREPL	5.48e-05	2	219	2	C0549225
Disease	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS	FGFR2 POR	5.48e-05	2	219	2	207410
Disease	Antley-Bixler syndrome	FGFR2 POR	5.48e-05	2	219	2	cv:C5234850
Disease	Antley-Bixler Syndrome, Autosomal Dominant	FGFR2 POR	5.48e-05	2	219	2	C2936791
Disease	Antley-Bixler Syndrome Phenotype	FGFR2 POR	5.48e-05	2	219	2	C2350233
Disease	venous thromboembolism, fibrinogen measurement	PLCG2 CPS1 NLRP3 LRP4 IL1R1	1.43e-04	67	219	5	EFO_0004286, EFO_0004623
Disease	pathological myopia	SPTBN1 SRPK2 CLSTN2 CNTN5 DNAH9 ROS1	1.85e-04	111	219	6	EFO_0004207
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	PIK3CD MTOR ATM	2.10e-04	16	219	3	C0334634
Disease	spleen volume	MYO9B CNTN5 TJP1 ELF1	2.90e-04	43	219	4	EFO_0600047
Disease	Cryopyrin-Associated Periodic Syndromes	PLCG2 NLRP3	3.26e-04	4	219	2	C2316212
Disease	Jeune thoracic dystrophy	IFT80 TTC21B	3.26e-04	4	219	2	cv:C0265275
Disease	Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	PLCG2 NLRP3	3.26e-04	4	219	2	C0409818
Disease	Familial Cold Autoinflammatory Syndrome 1	PLCG2 NLRP3	3.26e-04	4	219	2	C4551895
Disease	Familial cold urticaria	PLCG2 NLRP3	3.26e-04	4	219	2	C0343068
Disease	Familial cold autoinflammatory syndrome	PLCG2 NLRP3	3.26e-04	4	219	2	cv:C0343068
Disease	Kartagener syndrome (is_implicated_in)	DNAH5 DNAH11	3.26e-04	4	219	2	DOID:0050144 (is_implicated_in)
Disease	blood phosphate measurement	DCDC1 CYP24A1 TBX21 CD86 USP40 ZFHX3 TCF7L1	3.35e-04	174	219	7	EFO_0010972
Disease	fibrinogen measurement, tissue plasminogen activator measurement	PLEC CPS1 NLRP3 IL1R1	3.47e-04	45	219	4	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	PLEC CPS1 NLRP3 IL1R1	3.47e-04	45	219	4	EFO_0004623, EFO_0004792
Disease	creatinine measurement	DCDC1 CYP24A1 ADARB2 PTPN14 PLEC WDR1 ASCC3 SFMBT1 DSCAM POR CPS1 INTS8 SBNO2 SLF2 TNK2 ZFHX3 CGNL1 SLC14A2	4.85e-04	995	219	18	EFO_0004518
Disease	gastric ulcer	MYO9B JRK TTC33	4.86e-04	21	219	3	EFO_0009454
Disease	Muckle-Wells Syndrome	PLCG2 NLRP3	5.40e-04	5	219	2	C0268390
Disease	hexadecanedioate measurement	CLSTN2 CYP4Z2P	5.40e-04	5	219	2	EFO_0021055
Disease	Intellectual Disability	CDK8 RALGAPA1 SOX9 TPP1 FGFR2 ASCC3 NSD2 SYNE1 RTTN PREPL MTOR	5.52e-04	447	219	11	C3714756
Disease	Bronchiectasis	PIK3CD DNAH5 DNAH11	5.60e-04	22	219	3	C0006267
Disease	platelet measurement	MYO9B ITGB5 TBC1D14 PLCG2 PLEC RTTN CPS1 SLFN12L SEC14L5	6.15e-04	315	219	9	EFO_0005036
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC6 CYP24A1 NRP1 NSD2 ZFHX3 ATM	6.17e-04	139	219	6	DOID:3908 (is_implicated_in)
Disease	electrocardiography	SPTBN1 NHLRC2 GMEB2 TRANK1 FGFR2 PLEC WDR49 SFMBT1 RAF1 E2F6 USP40 ROS1	6.51e-04	530	219	12	EFO_0004327
Disease	Myasthenic Syndromes, Congenital	PLEC PREPL LRP4	7.27e-04	24	219	3	C0751882
Disease	Pseudoaphakia	ERCC6 TDRD7 ATM	7.27e-04	24	219	3	C0524524
Disease	Lens Opacities	ERCC6 TDRD7 ATM	7.27e-04	24	219	3	C1510497
Disease	Ischemic stroke, fibrinogen measurement	PLEC CPS1 NLRP3 IL1R1	7.49e-04	55	219	4	EFO_0004623, HP_0002140
Disease	Adenocarcinoma of large intestine	CDK8 RIPK1 ROS1 ATM PRKG2	7.60e-04	96	219	5	C1319315
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	PLEC CPS1 NLRP3 IL1R1	8.02e-04	56	219	4	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	Acute kidney injury	ADARB2 LINGO2 TLR5	8.22e-04	25	219	3	HP_0001919
Disease	calcium measurement	CYP24A1 SPTBN1 ABCA9 PLEC ASCC3 RAB3D CPS1 MLYCD CD86 USP40 ZFHX3 CGNL1 TCF7L1	8.95e-04	628	219	13	EFO_0004838
Disease	fibrinogen measurement, factor VII measurement	PLEC CPS1 NLRP3 IL1R1	9.15e-04	58	219	4	EFO_0004619, EFO_0004623
Disease	Lewy body dementia, Lewy body dementia measurement	MYO7A HMX3 HPS5	9.24e-04	26	219	3	EFO_0006792, EFO_0006799
Disease	lung carcinoma (is_implicated_in)	SOX9 CYP24A1	1.12e-03	7	219	2	DOID:3905 (is_implicated_in)
Disease	Hyperammonemia	CPS1 TLR5	1.12e-03	7	219	2	C0220994
Disease	10-undecenoate 11:1n1 measurement	CYP4Z1 CYP4Z2P	1.12e-03	7	219	2	EFO_0021099
Disease	lung small cell carcinoma (is_implicated_in)	CYP24A1 MTOR ATM	1.15e-03	28	219	3	DOID:5409 (is_implicated_in)
Disease	Ciliopathies	MYO7A IFT80 DNAH5 TTC21B DNAH11	1.40e-03	110	219	5	C4277690
Disease	apolipoprotein B measurement	CENPA PNLDC1 NHLRC2 ABCA9 PLEC RAF1 TBX21 AKNAD1 RAB3D MLYCD ZFHX3 RP1 DNAH11	1.46e-03	663	219	13	EFO_0004615
Disease	pneumococcal meningitis	CELSR1 ROS1	1.49e-03	8	219	2	EFO_1001114
Disease	brain aneurysm	SLC24A3 DSCAM LINGO2 RP1 CCDC171	1.58e-03	113	219	5	EFO_0003870
Disease	immature platelet fraction	MYO9B TBC1D14 PLEC RTTN SEC14L5	1.64e-03	114	219	5	EFO_0009187
Disease	Drug habituation	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0013170
Disease	Drug abuse	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0013146
Disease	Prescription Drug Abuse	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C4316881
Disease	Substance-Related Disorders	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0236969
Disease	Drug Use Disorders	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0013222
Disease	Drug Dependence	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C1510472
Disease	Substance Dependence	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0038580
Disease	Substance Use Disorders	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.70e-03	115	219	5	C0029231
Disease	Large cell carcinoma of lung	BMX MTOR ROS1	1.71e-03	32	219	3	C0345958
Disease	Substance abuse problem	ADARB2 DSCAM SYNE1 CDCP1 TTC21B	1.77e-03	116	219	5	C0740858
Disease	apolipoprotein A 1 measurement	AOC1 NEIL2 NHLRC2 ABCA9 CES2 NRP1 TRANK1 BTNL3 MYO1H LINGO2 CPS1 AGBL3 SLC12A3 CSNK2A2 TCF7L1	1.77e-03	848	219	15	EFO_0004614
Disease	retinal vasculature measurement	GJD2 SPTBN1 ADARB2 MYO3B FGFR2 DNAH5 DNAH9 RBM18 SYT13 PIWIL2 CPS1	1.78e-03	517	219	11	EFO_0010554
Disease	anemia (phenotype), response to ribavirin	CYP24A1 DNAH17	1.91e-03	9	219	2	EFO_0004272, GO_1901559
Disease	immature platelet measurement	MYO9B TBC1D14 PLEC RTTN SEC14L5	1.98e-03	119	219	5	EFO_0803541
Disease	Odontome	FGFR2 LRP4	2.37e-03	10	219	2	C0524730
Disease	response to carboplatin, response to antineoplastic agent	PLCG2 AKNAD1	2.37e-03	10	219	2	GO_0097327, GO_0097328
Disease	Tooth Abnormalities	FGFR2 LRP4	2.37e-03	10	219	2	C0040427
Disease	2-aminobutyrate measurement	LINGO2 EPG5	2.37e-03	10	219	2	EFO_0020017
Disease	urate measurement, bone density	PEBP4 TPRG1 VWA3B DNAH9 DSCAM SYNE1 SELENON PREPL CSNK2A2 USP40 TCF7L1 DNAH11	2.41e-03	619	219	12	EFO_0003923, EFO_0004531
Disease	Cataract	ERCC6 TDRD7 ATM	2.60e-03	37	219	3	C0086543
Disease	Malignant neoplasm of breast	ERCC6 CYP24A1 WDR53 PTPN14 FGFR2 DNAH9 RUSF1 RAF1 NSD2 SYNE1 UBR4 RUFY1 EPG5 TRMT2A MTOR ATM TCF7L1	2.87e-03	1074	219	17	C0006142
Disease	Jeune thoracic dystrophy	IFT80 TTC21B	2.89e-03	11	219	2	C0265275
Disease	Lymphoma, Lymphocytic, Intermediate	PIK3CD MTOR	2.89e-03	11	219	2	C0751958
Disease	lung cancer (is_marker_for)	SOX9 ERCC6 CYP24A1	3.03e-03	39	219	3	DOID:1324 (is_marker_for)
Disease	serum urea measurement	DCDC1 CYP24A1 CPS1 EPG5 SLC14A2 TTC33	3.45e-03	195	219	6	EFO_0009795
Disease	neutrophil count	NEIL2 SPTBN1 SRPK2 NHLRC2 PTPN14 ERAP2 TBC1D14 SPEF1 DSCAM PIK3R3 NBPF6 CPS1 NLRP3 SBNO2 SLFN12L FGFBP3 LRP4 RP1 TCF7L1 PHTF1	3.50e-03	1382	219	20	EFO_0004833
Disease	ulcerative colitis	NXPE1 ERAP2 PLCG2 SFMBT1 UBR4 SNAPC4 IL1R1 TTC33	3.71e-03	335	219	8	EFO_0000729
Disease	gestational age	ABCA9 VWA3B VARS1 SENP5 LINGO2	3.75e-03	138	219	5	EFO_0005112
Disease	cancer (implicated_via_orthology)	CENPA ITGB5 PIK3CD RAF1 MTOR ATM TPI1	4.02e-03	268	219	7	DOID:162 (implicated_via_orthology)
Disease	male infertility (implicated_via_orthology)	CENPA CSNK2A2	4.05e-03	13	219	2	DOID:12336 (implicated_via_orthology)
Disease	colorectal cancer, hormone replacement therapy	CYP24A1 SLC24A3 OR2F2 TLR5	4.23e-03	88	219	4	EFO_0003961, MONDO_0005575
Disease	fibromuscular dysplasia	SLC24A3 FGFR2 TBX21	4.27e-03	44	219	3	EFO_1000938
Disease	high grade glioma (implicated_via_orthology)	PIK3CD FGFR2 RAF1	4.27e-03	44	219	3	DOID:3070 (implicated_via_orthology)
Disease	platelet component distribution width	MYO9B NHLRC2 TRANK1 CNTN5 TBC1D14 ATP13A3 PLCG2 PLEC SYNE1 RTTN CPS1 TCF7L1 SEC14L5	4.42e-03	755	219	13	EFO_0007984
Disease	Adenocarcinoma of lung (disorder)	FGFR2 RAF1 TNK2 ROS1 ATM TPI1	4.51e-03	206	219	6	C0152013
Disease	adipose tissue measurement	CNTN5 MYO3B ARHGEF10	4.55e-03	45	219	3	EFO_0004764
Disease	Gastric Adenocarcinoma	TNK2 ROS1 ATM	4.55e-03	45	219	3	C0278701
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH5 DNAH11	4.71e-03	14	219	2	DOID:0050144 (implicated_via_orthology)
Disease	N-acetylglycine measurement	MYO3B CPS1	4.71e-03	14	219	2	EFO_0021002
Disease	ankylosing spondylitis	ERAP2 SNAPC4 IL1R1 TTC33	4.77e-03	91	219	4	EFO_0003898
Disease	amino acid measurement	CDK8 DCDC1 ADARB2 PEBP4 CNTN5 TXNDC16 OR2F2 SYNE1 LINGO2 CPS1 MLYCD CSNK2A2	4.97e-03	678	219	12	EFO_0005134
Disease	Primary Ciliary Dyskinesia	DNAH5 DNAH9 DNAH11	5.14e-03	47	219	3	C4551720
Disease	Neoplasm of uncertain or unknown behavior of bladder	MTOR ATM	5.40e-03	15	219	2	C0496930
Disease	Situs ambiguus	DNAH5 DNAH9	5.40e-03	15	219	2	C0266642
Disease	Benign neoplasm of bladder	MTOR ATM	5.40e-03	15	219	2	C0154017

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALKKRQLHTTWEEGL	SYT13	211	Q7L8C5
SKQGHVLKAWLDITR	TTC21B	141	Q7Z4L5
LIGNELAIKKLHSWL	ATAD5	1066	Q96QE3
VTLDGSKWKKHRQIV	CYP4Z2P	126	Q8N1L4
AVLHVLKAKRLGIWL	EPG5	691	Q9HCE0
SKGKIQAELDWRRKH	BTNL3	261	Q6UXE8
IGQLKRHGKNNWTLL	BAAT	341	Q14032
KHSQIWAIKNEDIKP	AGBL3	921	Q8NEM8
HDWTSGLQRLILKKE	ARHGEF10	786	O15013
DELVWILGKQHLLKT	ATG4A	26	Q8WYN0
TEDKILHIVIKRGWK	DNAJB5	206	O75953
VDSKAVSRLWGKHKN	ELF1	241	P32519
ELNHLGWRKIKLAVR	GJD2	271	Q9UKL4
RSWIGKEHKKFVQIL	C2orf69	341	Q8N8R5
IWDVKAHKSIGLELQ	CDCP1	126	Q9H5V8
RKLESKLTWHKVQNI	ATP13A3	691	Q9H7F0
LSRHRIWNLLKEGKS	ABCA9	651	Q8IUA7
QWLKALQKEIRGNPH	BMX	101	P51813
ELDITDNLRKKLHWA	CCDC171	31	Q6TFL3
LSWHINKLRETGKEA	CACHD1	571	Q5VU97
RKQEKGKTLLLHQWP	CFAP46	1071	Q8IYW2
ILREQANLKHDGPKW	DNAH11	2241	Q96DT5
VHLVAKWLGTLEKLL	DNAH11	3991	Q96DT5
DGEWHHLLIELKNVK	CELSR1	1771	Q9NYQ6
LQAWTDKQKGLEEKH	FAM186B	761	Q8IYM0
LKAVHSFLWSKKELR	AOC1	41	P19801
DSWTLRLHNLQIKDK	CD86	91	P42081
RLLAAKVNKHKPWIE	CLSTN2	31	Q9H4D0
SLLKIWHKQGQRVLL	ERCC6	846	Q03468
LTWAARQGHKNIVLK	ASZ1	186	Q8WWH4
WIGLNGSQILHKIDK	TNK2	331	Q07912
NKRNLKWHKLEVTPV	CCNB3	106	Q8WWL7
EILVAWKHIKESLGR	CNTN5	891	O94779
VHLAGKSTLKDWKRA	GMEB2	131	Q9UKD1
GRDASRWLNKHLKTL	NBPF4	116	Q96M43
LLHEHKGKKARLDWN	RAF1	101	P04049
WKERGIGNVKILRHK	RANBP2	1211	P49792
GKLALSKKLVVRWAH	RBM18	91	Q96H35
RHEKRVKLQIWDTAG	RAB3B	66	P20337
RHDKRIKLQIWDTAG	RAB3D	66	O95716
NGGHLCKLQLVWKKL	ADARB2	106	Q9NS39
ANKQKRHLLEALWLS	RIC1	726	Q4ADV7
LKLLALKVAAHLKWD	INTS8	81	Q75QN2
QWILKDLGKRRKHVV	IPP	206	Q9Y573
WKALLGRHQARLKAE	NSUN5	91	Q96P11
QHSKSKVLREKWLLQ	PALM2	41	Q8IXS6
WVALIEKALAKLHGS	CAPN15	621	O75808
TRILLSHFNWDKEKL	ARIH1	131	Q9Y4X5
IHEKQKESWQLRKGV	ANAPC1	66	Q9H1A4
NIKTLEHRGFKLNIW	ARL2	51	P36404
KQHLEWVGLVESKIR	PAPOLB	386	Q9NRJ5
WLKNGKEFKQEHRIG	FGFR2	191	P21802
RAHFWKQVLGGLRKK	FGFBP3	106	Q8TAT2
LILQKRHSGDDSQKW	DCDC1	741	M0R2J8
QHLLKQDREHLWKLI	POR	606	P16435
WLQDTQVHGKKLFLR	NEIL2	41	Q969S2
KWKRQLAAELEAANL	HMX3	281	A6NHT5
EINKLLREKGHWEVR	ISY1	76	Q9ULR0
PLQIWDKKVRNGHIK	CFAP20	21	Q9Y6A4
LHLIQKEGWKHRLFL	HPS5	56	Q9UPZ3
KWLLGLLNSQTKEHG	MLYCD	336	O95822
LEKWKEQNRAKPVHL	EPSTI1	91	Q96J88
EAGHIDIVKELIKWR	FEM1B	196	Q9UK73
DNIGHRLLQKHGWKL	GPATCH8	41	Q9UKJ3
LWGEHILALKNLKLD	PINK1	511	Q9BXM7
LWRFKARHGIKKLDA	JRK	136	O75564
KWKDNILANLNLKHG	LRRC36	476	Q1X8D7
KHEVLCRWILSVKKN	PDE5A	591	O76074
RHWLVTDIKGADLKK	PEBP4	111	Q96S96
LNFHLRKKVLEIQWG	FAM205A	891	Q6ZU69
IEKHWTFLLGNRKKT	KAT14	156	Q9H8E8
VGRALKAHRLQFWKK	CES2	526	O00748
KKLHFQDIIWVKLGN	NSD2	876	O96028
VSKLDGQHRQVLVWK	LRP6	731	O75581
LLLFVWSRGKGKHKN	LINGO2	561	Q7L985
LNLNHEWTPEKLRQK	LRRC8E	396	Q6NSJ5
RQHWKLRKVGDKILG	MED17	191	Q9NVC6
KEDAVNWLSGLKILH	PLCG2	116	P16885
SLRNKEVKGAWHKLL	OR2F2	291	O95006
EKIGWRKDALHLLVF	ITGB5	261	P18084
GNLKNGINDIKKHRW	PRKG2	696	Q13237
VFGVHLNKWQLDKKL	SLC24A3	596	Q9HC58
NAKLQHPLGVTWDKK	NHLRC2	471	Q8NBF2
WGQIFEKQRETKKHL	KICS2	226	Q96MD2
RLDGKNLVQEWLAKH	ALPI	246	P09923
DHWKEGRVLLHKSLK	NRP1	761	O14786
RLDGKNLVQEWLAKH	ALPG	246	P10696
KVLERKNHELVWQGK	PARP14	66	Q460N5
LNHKGVRQKRLNVWL	PIK3R3	316	Q92569
NHAVLKLAKGDEVWL	C1QTNF3	206	Q9BXJ4
KAWLRKHGEEQQLPA	EEF1AKMT4-ECE2	796	P0DPD8
LRKLWIEGIEHKHVL	EXOC4	111	Q96A65
RKKIELGWEVIKDHL	ATM	386	Q13315
LRLKKNIHPWVKQID	CPS1	931	P31327
KLWSVHGQKRLQEFL	CDC45	301	O75419
IHIKDGDWNEFRRKL	IL3	116	P08700
VLQWKAHDGIILKVD	IFT80	181	Q9P2H3
WHNLESAPKILRDVK	KLHL11	481	Q9NVR0
VEKKSKNHIRWIGSD	E2F6	116	O75461
LQILWKGGLKKQHDT	CYP24A1	71	Q07973
NIHLVARWLGTLDKK	DNAH17	3936	Q9UFH2
GWLKEIRKLQKSTHL	CENPA	46	P49450
NERWHLGKTIEKLQK	CGNL1	941	Q0VF96
WVKAIGRKAEALHNI	C7orf25	116	Q9BPX7
KVGWLIQLFHKKIES	BPI	181	P17213
AAWHKLILDHRIKLG	CCDC191	331	Q8NCU4
WKERHLKQIQIGLDQ	IFNK	106	Q9P0W0
LEWKQNVEKKGHGRI	AKNAD1	611	Q5T1N1
LQKGIIRHDSFWDKL	ACSL5	386	Q9ULC5
LHARTKWLKEGGLLL	PRMT6	171	Q96LA8
DHQQKKLRLIDWGLA	CSNK2A2	166	P19784
VLQGLKKNWEEVHKE	ENKUR	196	Q8TC29
EHRDLHWGNVLLKKT	HASPIN	646	Q8TF76
VRENWTHLLKKFDLG	ERAP2	876	Q6P179
IWNKALEKKGISHLE	CACTIN	211	Q8WUQ7
LDLAAKKGHWVILQN	DNAH9	3946	Q9NYC9
HLKTVENVAWKNGLA	CENPI	91	Q92674
LQKVFLSHADRKVWL	CDK8	81	P49336
LIQLRHWLQETHKGK	SEC14L5	246	O43304
KLHIIWKKDGVLLSG	SDK2	246	Q58EX2
ESIKFIKQKHGAIRW	IL1R1	501	P14778
LCWNEIKKKSHNLRA	DRP2	81	Q13474
NDLLKLWKHECKRVI	DNAH5	2816	Q8TE73
KDHAKGWLRLLKQDV	IL17RC	561	Q8NAC3
HLKRLTCLKLWHNKI	LRRC8D	681	Q7L1W4
LHQKLLERAKGKRNW	CROT	66	Q9UKG9
LLLDAERHTQIQWKK	NXPE1	386	Q8N323
IDKGKWLLKENHLLR	RP1	1741	P56715
WHNIKCEKGDKLRLF	MNDA	356	P41218
KKLHVSTINLQKAWG	MTOR	1256	P42345
GLKHLLCNLKKLWLV	NLRP3	821	Q96P20
IRVTWKAPKKHLQNG	DSCAM	1001	O60469
KGLQDAGWKTEKHQL	RUSF1	436	Q96GQ5
GGNKHLSNLTILWLK	RTTN	2066	Q86VV8
TRKLKTHLQHLRWKG	SYTL3	36	Q4VX76
VVEKKLWREQGLSRH	VARS1	391	P26640
GGSQLEVKLVLLWKH	SZT2	421	Q5T011
ERDKALRVLHGALWK	TRMT2A	121	Q8IZ69
AKWVQSHRDLPIKLN	EPRS1	1131	P07814
ERIWVELKKILVGNH	TRNT1	236	Q96Q11
WLITKEHIEGLLKAE	SESN1	176	Q9Y6P5
GKKNHVENLQKLRRW	RSAD2	196	Q8WXG1
GLQEAVRKLHKQWKD	SYNE1	996	Q8NF91
VRKLHKQWKDLQGEA	SYNE1	1001	Q8NF91
GRDASRWLNKHLKTL	NBPF5P	116	Q86XG9
GRDASRWLNKHLKTL	NBPF6	116	Q5VWK0
KQLKLHRKIHLWNSI	NBR1	321	Q14596
RWGLRLQKDVHKIEG	PIWIL2	551	Q8TC59
VNGAVLKWLKKEHLV	SAMD9	41	Q5K651
WTLIAKHLKGRLGKQ	MYBL2	106	P10244
NEKGVLLWDKIHKLQ	NT5DC3	346	Q86UY8
DIKEVNQALKGHAWL	RUFY1	626	Q96T51
QEKKIRHDILTGNWR	PNLDC1	126	Q8NA58
LRGTLEHKLKWTFKI	GUCA1B	86	Q9UMX6
QQARWVELEKPLKKH	PTPN14	71	Q15678
LKVKHLLSGQERTVW	PTPN14	1056	Q15678
VILENHLRGRKKALW	SBNO2	291	Q9Y2G9
NTEKRLWVHGLSKEQ	SEMG2	161	Q02383
KLRIWDTTQKEHLLK	WDR1	81	O75083
KDLVARIHGKWQEII	SLF2	1141	Q8IX21
HNAELSKTLGKLWRL	SOX9	131	P48436
EVLGHHLLKWIIKSN	SRPK1	166	Q96SB4
AAKVENKWHRVLLKG	TDRD7	966	Q8NHU6
NKWHRVLLKGILTNG	TDRD7	971	Q8NHU6
WAQLVNLAGSKLEKH	HERC2P3	996	Q9BVR0
RENLGKHWKNCARKL	RIPK1	591	Q13546
LIWKGHASLVQELKA	SDSL	146	Q96GA7
KQLWGLLIEETEKRH	SPTBN1	1571	Q01082
KWQVLNKAKSHIPEL	STRA8	86	Q7Z7C7
KILKIRHGWEDVTKI	STEAP1	316	Q9UHE8
KIHKAASRGQAWKLE	ANKRD30BL	41	A7E2S9
EKLWKHLFERELGVK	ACTRT1	86	Q8TDG2
LHEQVLDLGLTWKKI	ASCC3	36	Q8N3C0
RKIKDNAADWHNLIL	CINP	21	Q9BW66
VTLDGSKWKKHRQIV	CYP4Z1	126	Q86W10
TWGKVRKLLVDAIHN	UFSP2	161	Q9NUQ7
RLDKHNDLGWKLFGK	TBC1D14	251	Q9P2M4
IKKKLEHGLTRIWQD	VPS50	376	Q96JG6
KILWRKGIHLAFSEK	SENP5	6	Q96HI0
LVLWLKKLEAGLENH	TXNDC16	716	Q9P2K2
KGFSKKWALVRHQQI	ZNF599	206	Q96NL3
AHIRLWDLENGKQIK	WDR61	86	Q9GZS3
QRWQFHSIGLILKKL	RALGAPA1	101	Q6GYQ0
KKLRHLGNDEVHIVW	RALGAPA1	1896	Q6GYQ0
KGKTQLHKWAERLVV	PHLPP2	161	Q6ZVD8
KPDSWHVKDNRVKQL	SLFN12L	336	Q6IEE8
HFRLKKVENIKIWLS	PHTF1	581	Q9UMS5
KESAAINQILGRKWH	TCF7L1	371	Q9HCS4
LSNWGHLNRKVLKRL	SPEF1	66	Q9Y4P9
LKLEEWKGRLQVTEH	TIMMDC1	231	Q9NPL8
KAENKLVHSILLWGA	SELENON	441	Q9NZV5
FEVLGHHLLKWIIKS	SRPK2	166	P78362
SKDKVLRLWDIQHQL	WDR49	81	Q8IV35
KIDHWNNEKERILLV	TPRG1	101	Q6ZUI0
EQIKIWFSAQRLKHG	ZHX1	326	Q9UKY1
KLKKELTGLNHWVRA	TRAF7	511	Q6Q0C0
QAQEVHEKLRGWLKS	TPI1	181	P60174
LARLLLVTKWNKHED	PIK3CD	546	O00329
LIANGHTKWLNKRKI	SLC12A3	691	P55017
VFWGLDKKLAQRKHF	ATP6V1A	431	P38606
GLQWHADGRLTKKLN	PREPL	516	Q4J6C6
VWHRRLKNQKSAKEG	ROS1	1881	P08922
IVKNVHDLLAKLAWD	USP9Y	446	O00507
LPKLNIEHGEKVNWL	WDR53	316	Q7Z5U6
LDVEKEWGKLHVAIL	PLEC	501	Q15149
EWGKLHVAILEREKQ	PLEC	506	Q15149
GLSHALRKQAWKFLL	TBC1D15	346	Q8TC07
HIEGDWAGRNRKLLK	ZNF862	121	O60290
HIKGIREKQEKPLWQ	ZNF658	86	Q5TYW1
SWLAIRIGKNHKEVE	TJP1	556	Q07157
LLEAWKNEVKEKGHV	ZNF512B	736	Q96KM6
RHLKNEAEWQEILAK	SFMBT1	236	Q9UHJ3
RLHFSLKKGRWNLKE	SNAPC4	446	Q5SXM2
NPKIWKLDSKIHQGA	TRIP4	556	Q15650
SEKWLQLHGLKSNKL	VWA3B	36	Q502W6
KTLRIWDLNKHGKQI	WSB2	176	Q9NYS7
HVFIWDLRKGEKILI	WDR3	46	Q9UNX4
ILAIIGILHWQEKKA	ITFG1	581	Q8TB96
EKLAKKGLWHSFLLL	TRANK1	131	O15050
EWTQGLQKRLKHLKG	TRANK1	826	O15050
TRHLDKVLKRGDWDI	PIGG	196	Q5H8A4
GWFLHKLSQQILKKE	TLR5	826	O60602
AIVELKNKPARWHKA	UBR4	3601	Q5T4S7
EIHAQAQLWLKRDPK	UBR4	4051	Q5T4S7
GLHQADIKLTVWKRL	TRIM50	271	Q86XT4
RIWLKDKHLALQFID	SLC14A2	106	Q15849
LKKSGLQGDAWHLRK	USP40	876	Q9NVE5
QAGVKKHSQKWLRGL	WDR87	1086	Q6ZQQ6
KLRVALNNHLLWSKF	TBX21	136	Q9UL17
WERGLRHAKEVLKKA	ZC3H18	301	Q86VM9
KALVKGLHDSQRLQW	VWA5B1	811	Q5TIE3
AHIKEGGKANEWRLK	ZFHX3	1016	Q15911
DEGNWLHAIKRRKEI	TTC33	36	Q6PID6
LHTVQKWLLAAGAQK	TPP1	96	O14773
GLWVKLTKEQLAEHL	HECTD3	116	Q5T447
DGAHRKVLLWQNLEK	LRP4	541	O75096
KKRQAAIKLEAHWRG	MYO1H	726	Q8N1T3
AILEKSRLDHWVLGK	MYO3B	1026	Q8WXR4
KTLEKWAQLAIAAHK	MYO7A	1426	Q13402
DWIVLRINHALLNKK	MYO9B	491	Q13459